CrushSCI.com
126.0Average days
132Median days
2Fastest days
317Longest days
2282025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

2 days

Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis

Authors
Francesca Lorenzini; Maria Caterina MioneShow moreShow less
Affiliations
1. Experimental Cancer Biology, Department of Cellular, Computational and Integrative Biology (CIBIO) University of Trento ItalyShow moreShow less
Source PDF DOI Publisher page
92 days

Patient therapy outcome modeling in cancer organoids is improved by cancer‐associated fibroblasts and organoid assembly convolution

Authors
Marcin Grochowski; Liudmyla Dolinchuk; Michał Jerzak; Albert Gandurski; Tomasz Grochowski; Weronika Wojtyś; Maciej Zadrożny; Wojciech Kaźmierczak; Małgorzata Lenarcik; Marta Matejak‐Górska; Radosław Samsel; Tomasz Olesiński; Dawid WalerychShow moreShow less
Affiliations
1. Mossakowski Medical Research Institute PAS Warsaw Poland; 2. Doctoral School of Translational Medicine Center for Postgraduate Medical Education Warsaw Poland; 3. Medical University of Warsaw Poland; 4. Maria Skłodowska‐Curie National Research Institute of Oncology Warsaw Poland; 5. Clinical Department of Gastroenterological Surgery and Transplantology National Medical Institute of the Ministry of the Interior and Administration Warsaw PolandShow moreShow less
Source PDF DOI Publisher page
317 days

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

Authors
Konrad Stawiski; Júlia Perera‐Bel; Alejo Rodriguez‐Vida; Nuria Juanpere; Jihyun Lee; Daniel E. Michaud; Jennifer L. Guerriero; Kent W. Mouw; Aristotelis Bamias; Filipe L. F. Carvalho; Joaquim BellmuntShow moreShow less
Affiliations
1. Department of Radiation Oncology Dana Farber Cancer Institute Boston MA USA; 2. Department of Biostatistics and Translational Medicine Medical University of Lodz Poland; 3. PSMAR Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain; 4. Medical Oncology Department Hospital del Mar, CIBERONC Barcelona Spain; 5. Department of Urology Brigham and Women's Hospital Boston MA USA; 6. Division of Breast Surgery, Department of Surgery Brigham and Women's Hospital Boston MA USA; 7. Harvard Medical School Boston MA USA; 8. Department of Radiation Oncology Brigham and Women's Hospital Boston MA USA; 9. National and Kapodistrian University of Athens Greece; 10. Department of Medical Oncology Dana Farber Cancer Institute Boston MA USAShow moreShow less
Source PDF DOI Publisher page
20 days

Creating a smoother path to scientific publication

Authors
Thomas Lemberger; Kevin M. RyanShow moreShow less
Affiliations
1. EMBO Heidelberg Germany; 2. FEBS Press Cambridge UK; 3. Cancer Research UK Scotland Institute Glasgow UK; 4. School of Cancer Sciences University of Glasgow Glasgow UKShow moreShow less
Source PDF DOI Publisher page
68 days

Interpreting the effects of DNA polymerase variants at the structural level

Authors
Matteo Arnaudi; Karolina Krzesińska; Ludovica Beltrame; Pablo Sánchez‐Izquierdo Besora; Matteo Tiberti; Mef Nilbert; Anna Rohlin; Elena PapaleoShow moreShow less
Affiliations
1. Cancer Structural Biology Danish Cancer Institute Copenhagen Denmark; 2. Cancer Systems Biology, Section for Bioinformatics, Department of Health and Technology Technical University of Denmark Lyngby Denmark; 3. Institute of Clinical Medicine, Dept. Oncology and Pathology Lund University Sweden; 4. Department of Clinical Research Copenhagen University Hospital Amager and Hvidovre Denmark; 5. Department of Clinical Genetics and Genomics Sahlgrenska University Hospital Gothenburg Sweden; 6. Department of Laboratory Medicine Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg SwedenShow moreShow less
Source PDF DOI Publisher page
162 days

ESR1 methylation and ESR1 mutations in circulating tumor cells ( CTCs ) and paired plasma‐ cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

Authors
Dimitra Stergiopoulou; Athina Markou; Eleonora Nicolo; Mara S Serafini; Qiang Zhang; Youbin Zhang; Lorenzo Gerratana; Andrew A. Davis; Huiping Liu; William J Gradishar; Carolina Reduzzi; Massimo Cristofanilli; Evi LianidouShow moreShow less
Affiliations
1. Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry University of Athens Athens Greece; 2. Division of Hematology and Medical Oncology Weill Cornell Medicine/New York‐Presbyterian Hospital New York NY USA; 3. Robert H. Lurie Cancer Center of Northwestern University Feinberg School of Medicine Chicago IL USA; 4. Department of Medical Oncology Centro di Riferimento Oncologico di Aviano (CRO), IRCCS Aviano Italy; 5. Division of Oncology Washington University St. Louis MO USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.